Rising Tide Foundation for Clinical Cancer Research (RTFCCR) supports innovative and unique patientcentered clinical trials with the potential to impact the lives of cancer patients timely. Our overall goal is to improve cancer patients' treatment options and quality of life by funding clinical studies focused on therapy optimization, disease and treatment burden, and early detection and intervention. We fund phase I to phase III interventional clinical trials. Please note we do not support basic research, observational or epidemiological studies, or trials that could generate revenue for start-ups or pharmaceutical companies.
Maximum award and duration
Please be aware that RTFCCR does not cover the full clinical trial cost. RTFCCR normally funds USD 100,000 per each year of the trial duration. Awarded funds will be paid on a milestone-driven basis. Funds should be used for non-reimbursable approved treatment and study-related patient-care costs, including patient participation costs such as travel and parking, extraordinary translational and imaging studies, and supplies. Funds may also be used to support the salary of the principal investigator, patient partner, and other key personnel. Equipment costs will be funded only if use is demonstrated to be entirely related to the project financed by RTFCCR.
A grant usually lasts up to five years. RTFCCR will disburse the funds only if the recipient follows reporting and participating in accrual requirements outlined in the grant agreement.
From a reviewer’s perspective, strong Rising Tide clinical research proposals generally exhibit:
✔ Clear Patient-Centric Impact
Projects must articulate how outcomes will tangibly improve patient outcomes or care within a few years. Rising Tide Foundation
✔ Scientific Rigor & Innovation
Proposals should include robust methodology, clear hypotheses, and appropriate trial design or intervention mechanisms. Rising Tide Foundation
✔ Active Patient Involvement
Meaningful inclusion of patient partners in study design, conduct, and dissemination is essential and often required. Rising Tide Foundation
✔ Feasibility & Milestone Planning
Realistic budgets, timelines with clear milestones, and evidence of institutional and co-funding support strengthen competitiveness. Rising Tide Foundation
✔ Scalability & Equity
Especially for ACCESS and supportive care awards, proposals with scalable, low-cost interventions and equity reach (e.g., LMIC applicability) are favoured. Rising Tide Foundation
✔ Submit a concise LOI: Early screening reduces time to invitation for full proposals. Rising Tide Foundation
✔ Integrate patients from day one: Early and meaningful patient engagement should be embedded and funded. Rising Tide Foundation
✔ Demonstrate co-funding: For larger awards, show confirmed or planned co-financial support. Rising Tide Foundation
✔ Align with strategic focus: Include therapy optimization, early detection/ intervention, or disease burden mitigation. Rising Tide Foundation
✔ Plan for data and outcomes: Lay out clinical endpoints and measurable impact within 3–5 years. Rising Tide Foundation
| Programme | Focus | Key Features | Funding Example |
|---|---|---|---|
| RTFCCR Clinical Grants | Interventional clinical cancer research | Patient partners; impact within years | Variable tailored funding Rising Tide Foundation |
| ACCESS Award | Scalable, equitable cancer solutions | 50% co-funding required | Up to $500,000 Rising Tide Foundation |
| Early Career Supportive Care | Supportive care clinical trials | Early career + mentorship | ~$245,000/4 yrs Rising Tide Foundation |
| Pre-application Grants | Patient partner early engagement | Small gap-funding | ~$1,000–$3,000 Rising Tide Foundation |
🔍 When Rising Tide Funding Is a Good Fit
✔ You are an independent clinical investigator planning an interventional cancer trial with clear patient impact. Oncodaily
✔ Your research application includes patient partners and measurable outcomes. Rising Tide Foundation
✔ You seek scalable solutions that can impact clinical practice or equity globally. Rising Tide Foundation
✔ You are an early career investigator focusing on supportive care with a mentor.
Applicants must hold a doctoral degree and have a faculty appointment (or equivalent) with an academic institution, including research institutions that are not formally associated with a university, at the time of the award term. Both early-career and established investigators are encouraged to apply.
An applicant must be an independent investigator with demonstrated experience and training to be able to organize, manage, and implement the clinical trial to meet milestones and timelines, and to protect the rights and welfare of the human subject participant.
The application must convey the institution's commitment to both the applicant and the proposed research activities. RTFCCR does not have any geographical or cancer type restrictions. International teams are welcome. Typically, a grantee can only have one active grant at a time.
To be eligible for funding, proposed clinical trials must meet the following criteria:
- Clinical trials must be interventional, early to late stage (Phase 1, 2, and 3); they may include secondary non-clinical endpoints.
- Applications must have patient partner involvement (see the section “Patient partner involvement in research” on page 6 for more information). If this is not the case, you can apply for a pre-application grant. Please find more information here (Pre-application Grants - Rising Tide Foundation).
- The application must be submitted in English.
Sponsor Institute/Organizations: Rising Tide Foundation
Sponsor Type: Corporate/Non-Profit
Address: Herrenacker 15 8200 Schaffhausen
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
$500,000
Affiliation: Rising Tide Foundation
Address: Herrenacker 15 8200 Schaffhausen
Website URL: https://www.risingtide-foundation.org/clinical-cancer-research-how-to-apply/
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.